Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.75
-0.07 (-0.51%)
May 2, 2025, 4:00 PM EDT - Market closed
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.18 billion as of May 2, 2025. Its market cap has decreased by -32.96% in one year.
Market Cap
1.18B
Enterprise Value
944.21M
1-Year Change
-32.96%
Ranking
Category
Stock Price
$13.75
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.18B, an increase of 466.34%. That is a compound annual growth rate of 20.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 1.18B | 4.67% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 807.25B |
| Johnson & Johnson | 376.09B |
| UnitedHealth Group | 374.50B |
| AbbVie | 345.13B |
| Novo Nordisk | 293.18B |
| Abbott Laboratories | 226.76B |
| Novartis AG | 223.05B |
| AstraZeneca | 221.80B |